未登录 分享 收藏
Predictors for m-FOLFOXIRI plus cetuximab in RAS/BRAF wild-type and left-sided mCRC: the DEEPER trial (JACCRO CC13) Natsume, S.; Sekikawa, T.; Takagane, A.; Sawada, K.; Bando, H.; Yamada, T.; Nakayama, H.; Uchima, Y.; Shiraishi, T.; Kizaki, J.; Furuya, T.; Takeuchi, M.; Ichikawa, W.; Fujii, M.; Sunakawa, Y.; Tsuji, A. 分享 收藏
分享 收藏
Modified (m)-FOLFOXIRI plus cetuximab versus bevacizumab for right-sided or BRAF mutant metastatic colorectal cancer (mCRC): Subgroup analysis of the DEEPER trial (JACCRO CC-13) Sunakawa, Y.; Shiozawa, M.; Kawai, T.; Ota, H.; Yasui, H.; Kochi, M.; Manaka, D.; Ohori, H.; Matsuura, M.; Shinohara, Y.; Takeuchi, M.; Ichikawa, W.; Fujii, M.; Tsuji, A. 分享 收藏
Plasma Angiogenic Factors as Predictors of the Efficacy of Second-line Chemotherapy Combined with Angiogenesis Inhibitors in Metastatic Colorectal Cancer: Results From the GI-SCREEN CRC-Ukit Study Yuki, Satoshi; Yamazaki, Kentaro; Sunakawa, Yu; Taniguchi, Hiroya; Bando, Hideaki; Shiozawa, Manabu; Nishina, Tomohiro; Yasui, Hisateru; Kanazawa, Akiyoshi; Ando, Koji; Horita, Yosuke; Goto, Masahiro; Okano, Naohiro; Moriwaki, Toshikazu; Satoh, Taroh; Tsuji, Akihito; Yamashita, Kaname; Asano, Chiharu; Abe, Yukiko; Nomura, Shogo; Yoshino, Takayuki 分享 收藏
RAS status in ctDNA and efficacy of FOLFIRI plus ramucirumab in 2nd-line therapy for RAS wild-type mCRC: JACCRO CC-16AR Sunakawa, Yu; Yasui, Hisateru; Matsuura, Masato; Mine, Takashi; Yuasa, Yasuhiro; Watanabe, Takanori; Kinjo, Tatsuya; Okita, Yoshihiro; Okuyama, Hiroyuki; Yuki, Satoshi; Miyakawa, Koki; Kobara, Ayana; Ichikawa, Wataru; Fujii, Masashi; Tsuji, Akihito 分享 收藏
An inter-facility linkage case for palliative care and cancer pharmacotherapy in the Kagawa Medical Information Network Murakami, Akitsu; Nishiuchi, Takamasa; Nomura, Kotone; Shigeta, Hiroe; Okuyama, Hiroyuki; Okita, Yoshihiro; Kita, Ikuhiro; Tsukamoto, Sena; Oue, Sachiko; Uematsu, Kazuyo; Tsuji, Akihito 分享 收藏
Survival analysis of m-FOLFOXIRI plus cetuximab vs. bevacizumab in RAS wild-type mCRC: The DEEPER trial (JACCRO CC-13) Tsuji, Akihito; Endo, Izuru; Kobayashi, Kenji; Miyamoto, Yuji; Kusumoto, Tetsuya; Yuasa, Yasuhiro; Miwa, Keisuke; Kochi, Mitsugu; Sagawa, Tamotsu; Kotaka, Masahito; Kubota, Yutaro; Sunakawa, Yu; Sekikawa, Takashi; Nakamura, Masato; Takeuchi, Masahiro; Ichikawa, Wataru; Fujii, Masashi 分享 收藏
分享 收藏
An update analysis of the JACCRO CC-16: Ramucirumab plus FOLFIRI for RAS wild-type mCRC refractory to anti-EGFR antibody Manaka, Dai; Tsuji, Akihito; Shibutani, Masatsune; Ishibashi, Keiichiro; Yabuno, Taichi; Okamura, Shu; Furuya, Takumi; Tanaka, Chihiro; Nakamura, Masato; Sagawa, Tamotsu; Watanabe, Takanori; Shiozawa, Manabu; Sunakawa, Yu; Ota, Hirofumi; Kotaka, Masahito; Okuyama, Hiroyuki; Okita, Yoshihiro; Ichikawa, Wataru; Fujii, Masashi 分享 收藏
Modified (m)-FOLFOXIRI plus cetuximab treatment and predictive clinical factors for RAS/BRAF wild-type and left-sided metastatic colorectal cancer (mCRC): The DEEPER trial (JACCRO CC-13) Sunakawa, Y.; Shiozawa, M.; Watanabe, T.; Ota, H.; Yasui, H.; Kochi, M.; Manaka, D.; Ohori, H.; Yamaguchi, T.; Matsuura, M.; Shinohara, Y.; Miyake, T.; Sagawa, T.; Tanaka, C.; Okamura, S.; Takeuchi, M.; Ichikawa, W.; Fujii, M.; Tsuji, A. 分享 收藏
Ramucirumab plus FOLFIRI as second-line treatment for patients with RAS wild-type metastatic colorectal cancer previously treated with anti-EGFR antibody: JACCRO CC-16 Yasui, H.; Okita, Y.; Nakamura, M.; Sagawa, T.; Watanabe, T.; Kataoka, K.; Manaka, D.; Shiraishi, K.; Akazawa, N.; Okuno, T.; Shimura, T.; Shiozawa, M.; Sunakawa, Y.; Ota, H.; Kotaka, M.; Okuyama, H.; Takeuchi, M.; Ichikawa, W.; Fujii, M.; Tsuji, A. 分享 收藏
Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study) TP53基因的突变谱与晚期胃癌的nivolumab治疗效果相关 (TP53MUT研究) Ando, Koji; Nakamura, Yoshiaki; Kitao, Hiroyuki; Shimokawa, Mototsugu; Kotani, Daisuke; Bando, Hideaki; Nishina, Tomohiro; Yamada, Takanobu; Yuki, Satoshi; Narita, Yukiya; Hara, Hiroki; Ohta, Takashi; Esaki, Taito; Hamamoto, Yasuo; Kato, Ken; Yamamoto, Yoshiyuki; Minashi, Keiko; Ohtsubo, Koushiro; Izawa, Naoki; Kawakami, Hisato; Kato, Takeshi; Satoh, Taroh; Okano, Naohiro; Tsuji, Akihito; Yamazaki, Kentaro; Yoshino, Takayuki; Maehara, Yoshihiko; Oki, Eiji 分享 收藏
Novel endoscopic duodenal observation protocol based on Seven Pictures Rule for detecting duodenal neoplasms during esophagogastroduodenoscopy: Prospective observational study Kozuka, Kazuhiro; Kobara, Hideki; Matsui, Takanori; Fujisawa, Akihiko; Tatsuta, Miwa; Kobayashi, Mitsuyoshi; Yasuda, Mitsugu; Nakatani, Kaho; Tada, Naoya; Chiyo, Taiga; Kobayashi, Nobuya; Yachida, Tatsuo; Nishiyama, Noriko; Fujihara, Shintaro; Kondo, Akihiro; Okano, Keiichi; Tsuji, Akihito; Masaki, Tsutomu 分享 收藏
The BEETS (JACCRO CC-18) trial: an observational and translational study of BRAF-mutated metastatic colorectal cancer Inagaki, Chiaki; Matoba, Ryo; Yuki, Satoshi; Shiozawa, Manabu; Tsuji, Akihito; Inoue, Eisuke; Muro, Kei; Ichikawa, Wataru; Fujii, Masashi; Sunakawa, Yu 分享 收藏
Modified (m)-FOLFOXIRI plus cetuximab versus m-FOLFOXIRI plus bevacizumab as initial treatment for RAS and BRAF wild-type metastatic colorectal cancer: Updated survival analysis of the DEEPER trial by JACCRO Sunakawa, Y.; Shiozawa, M.; Watanabe, T.; Ota, H.; Yasui, H.; Kochi, M.; Manaka, D.; Ohori, H.; Yamaguchi, T.; Kyogoku, T.; Sagawa, T.; Kubota, Y.; Masuishi, T.; Kotaka, M.; Sekikawa, T.; Shimada, K.; Nakamura, M.; Takeuchi, M.; Ichikawa, W.; Fujii, M.; Tsuji, A. 分享 收藏
First-line treatment with CET/PAN vs. BEV in elderly patients with RAS WT mCRC: A multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum Yamamoto, K.; Hirose, T.; Takashima, A.; Yamazaki, K.; Yukami, H.; Uetake, H.; Tsuda, M.; Suto, T.; Moriwaki, T.; Sugimoto, N.; Ojima, H.; Takii, Y.; Yasui, H.; Esaki, T.; Tsuji, A.; Goto, M.; Sawada, R.; Otsu, S.; Shinozaki, K.; Nagashima, K.; Shimada, Y. 分享 收藏
QUATTRO-II: A multicenter randomized trial comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer: Efficacy and safety analysis Kotaka, M.; Bando, H.; Satake, H.; Kotani, D.; Hamaguchi, T.; Shiozawa, M.; Ikumoto, T.; Masuishi, T.; Yasui, H.; Kagawa, Y.; Oki, E.; Yamamoto, Y.; Kawakami, H.; Boku, S.; Komatsu, Y.; Taniguchi, H.; Muro, K.; Yamazaki, K.; Misumi, T.; Yoshino, T.; Kato, T.; Tsuji, A. 分享 收藏
Tumor response as a predictor of survival for RAS-WT left-sided mCRC administered first-line molecularly targeted drugs: An observational study by the Japanese Society for Cancer of the Colon and Rectum Hirose, T.; Takashima, A.; Yamazaki, K.; Yukami, H.; Uetake, H.; Tsuda, M.; Suto, T.; Moriwaki, T.; Sugimoto, N.; Ojima, H.; Takii, Y.; Yasui, H.; Esaki, T.; Tsuji, A.; Goto, M.; Sawada, R.; Otsu, S.; Shinozaki, K.; Nagashima, K.; Shimada, Y. 分享 收藏
A Multicenter, Phase II Trial of Schedule Modification for Nab-Paclitaxel in Combination with Ramucirumab for Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer: The B-RAX Trial (JACCRO GC-09) Kawabata, Ryohei; Izawa, Naoki; Suzuki, Takahisa; Nagahisa, Yoshio; Nishikawa, Kazuhiro; Takahashi, Masazumi; Nakamura, Masato; Ishiguro, Atsushi; Katsuya, Hiroo; Hihara, Jun; Manaka, Dai; Negoro, Yuji; Tsuji, Akihito; Takahashi, Takao; Kochi, Mitsugu; Azuma, Mizutomo; Kadowaki, Shigenori; Michimae, Hirofumi; Sunakawa, Yu; Ichikawa, Wataru; Fujii, Masashi 分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
